Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_16342 | 20 | 0.42 | Mlig455_012507 | Neo: - Age: - |
Mlig455_012507 {REF} {Length: 1825} {Pfam: Calcium-activated potassium channel, beta subunit [PF03185.17, score=61.0]} {Smed: dd_Smed_v6_14020_0_1, dd_Smed_v6_14020_0_1, [RH, Score=132, Expect=2e-38]} {RNA1509_23873} {RNA1310_73480} {RNA815_38079} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -3.527 | 0.822 | 0.99934 | 1.00000 | |
RegionR2 | 2.193 | 0.822 | 0.53834 | 0.90729 | |
RegionR3 | 0.913 | 0.822 | 0.45791 | 0.96794 | |
RegionR4 | 2.703 | 0.822 | 0.23275 | 0.52665 | |
RegionR5 | -0.606 | 0.822 | 0.57824 | 0.93692 | |
RegionR6 | 0.312 | 0.822 | 0.61623 | 1.00000 | |
RegionR7 | 1.207 | 0.822 | 0.47918 | 1.00000 | |
RegionR8 | -3.196 | 0.822 | 0.99941 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.348 | 0.822 | 0.99984 | 1.00000 | |
RegenerationR2 | -2.623 | 0.822 | 0.44468 | 0.84291 | |
RegenerationR3 | -1.824 | 0.822 | 0.55712 | 0.88710 | |
RegenerationR4 | -4.198 | 0.822 | 0.24701 | 0.69496 | |
RegenerationR5 | -1.673 | 0.822 | 0.25245 | 0.68552 | |
RegenerationR6 | -2.908 | 0.822 | 0.25697 | 0.60698 | |
RegenerationBL | -2.532 | 0.822 | 0.99978 | 1.00000 | |
RegenerationTP | -2.205 | 0.822 | 0.99973 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_16342 | 20 | 0.42 | Mlig455_012507 | Neo: - Age: - |
4 | 1.000 | 1.000 | 1.000 | 1.000 | - | - | Mlig455_012507 {REF} {Length: 1825} {Pfam: Calcium-activated potassium channel, beta subunit [PF03185.17, score=61.0]} {Smed: dd_Smed_v6_14020_0_1, dd_Smed_v6_14020_0_1, [RH, Score=132, Expect=2e-38]} {RNA1509_23873} {RNA1310_73480} {RNA815_38079} | |
2. | MligTC455_12894 | 84 | 1.75 | Mlig455_024418, Mlig455_024572 | Neo: - Age: - Region-enriched R2: 5.211/0.02671 |
SLC46A2 | 1.879 | - | 0.962 | - | 0.917 | - | - | Mlig455_024418 {REF} {Length: 2094} {Pfam: Major Facilitator Superfamily [PF07690.18, score=30.9]} {Human: ENSG00000119457, SLC46A2, solute carrier family 46 member 2, [Score=72.4, Expect=2e-13]} {Mouse: ENSMUSG00000020829, Slc46a1, solute carrier family 46, member 1, [Score=55.1, Expect=5e-08]} {Dmel: FBgn0030576, CG15890, [Score=68.9, Expect=1e-12]} {Celegans: WBGene00012811, Y43F8A.5, [Score=65.9, Expect=9e-12]} {Smed: dd_Smed_v6_10822_0_1, dd_Smed_v6_10822_0_1, [Score=187, Expect=2e-55]} {RNA1509_40290} {RNA1310_44254} {RNA815_43004} Mlig455_024572 {REF} {Length: 1344} {Pfam: Major Facilitator Superfamily [PF07690.18, score=30.9]} {Human: ENSG00000119457, SLC46A2, solute carrier family 46 member 2, [Score=72.4, Expect=2e-13]} {Mouse: ENSMUSG00000020829, Slc46a1, solute carrier family 46, member 1, [Score=55.1, Expect=5e-08]} {Dmel: FBgn0030576, CG15890, [Score=68.9, Expect=1e-12]} {Celegans: WBGene00012811, Y43F8A.5, [Score=65.9, Expect=9e-12]} {Smed: dd_Smed_v6_10822_0_1, dd_Smed_v6_10822_0_1, [Score=187, Expect=2e-55]} {RNA1509_40290} {RNA1310_71457} {RNA815_15082} |
3. | MligTC455_17479 | 32 | 0.66 | Mlig455_032081, Mlig455_070278 | Neo: - Age: logFC(26M/2M)=-0.516 |
CHRNA3 | 1.828 | - | 0.971 | - | 0.857 | - | - | Mlig455_032081 {REF} {Length: 2787} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=230.7]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.4]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=368, Expect=1e-121]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=5e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=6e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=361, Expect=3e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=381, Expect=3e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=614, Expect=0.0]} {RNA1509_28642} {RNA1310_34709} {RNA815_44960} Mlig455_070278 {REF} {Length: 2270} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=232.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.2]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=369, Expect=7e-122]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=4e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=9e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=362, Expect=1e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=382, Expect=2e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=616, Expect=0.0]} {RNA1509_16247} {RNA1310_34709} {RNA815_44960} |
4. | MligTC455_29238 | 48 | 1.01 | Mlig455_063305 | Neo: - Age: - |
1.818 | - | 0.842 | - | 0.976 | - | - | Mlig455_063305 {REF} {Length: 892} {TRANSSPLICED} {RNA1310_67367} {RNA815_37220} | |
5. | MligTC455_49843 | 70 | 1.46 | Mlig455_058264, Mlig455_058281, Mlig455_070786 | Neo: - Age: - |
CHRNA3, CHRNA7 | 1.715 | - | 0.962 | - | 0.753 | - | - | Mlig455_058264 {REF} {Length: 2377} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.7]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=224, Expect=4e-66]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=216, Expect=2e-63]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=223, Expect=8e-66]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=220, Expect=8e-65]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=219, Expect=6e-65]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=213, Expect=4e-62]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=240, Expect=3e-72]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=229, Expect=7e-69]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=227, Expect=1e-67]} {RNA1310_31785} {RNA815_40862} Mlig455_058281 {REF} {Length: 2912} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=179.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=105.5]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=238, Expect=4e-71]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=236, Expect=1e-70]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=231, Expect=2e-69]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=229, Expect=4e-68]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=240, Expect=3e-72]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=232, Expect=3e-69]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=231, Expect=7e-69]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=228, Expect=3e-68]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=252, Expect=2e-76]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=250, Expect=1e-76]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=239, Expect=7e-72]} {RNA1310_31785} {RNA815_40862} Mlig455_070786 {REF} {Length: 1486} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=36.1]} {RNA1310_31785} {RNA815_43410} |
6. | MligTC455_41722 | 271 | 5.65 | Mlig455_058499 | Neo: - |
1.703 | - | 0.953 | - | 0.750 | - | - | Mlig455_058499 {REF} {Length: 634} {RNA1509_12988, RNA1509_17403} {RNA1310_82552.1, RNA1509_12988, RNA1509_17403} {RNA1509_12988, RNA1509_17403, RNA815_43140.1} | |
7. | MligTC455_13669 | 41 | 0.85 | Mlig455_068960 | Neo: - Age: - |
1.661 | - | - | 0.702 | 0.959 | - | - | Mlig455_068960 {REF} {Length: 2108} {Pfam: ZIP Zinc transporter [PF02535.24, score=31.7]} {Celegans: WBGene00018897, zipt-2.4, Zrt (ZRT), Irt-(IRT-) like Protein Transporter, [Score=47.8, Expect=1e-05]} {RNA1310_20142} {RNA815_47479} | |
8. | MligTC455_06200 | 8 | 0.17 | Mlig455_022367 | Neo: - Age: - |
1 | - | - | - | 1.000 | - | - | Mlig455_022367 {REF} {Length: 738} {Pfam: WSC domain [PF01822.21, score=44.0]; PAN domain [PF00024.28, score=20.8]} {RNA1310_89673} {RNA815_64813} | |
9. | MligTC455_09115 | 8 | 0.17 | Mlig455_062552 | Neo: - Age: - |
1 | - | - | - | 1.000 | - | - | Mlig455_062552 {REF} {Length: 2058} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=143.1]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=57.8, Expect=1e-08]} {Smed: dd_Smed_v6_15195_0_1, dd_Smed_v6_15195_0_1, [Score=52.0, Expect=6e-07]} {RNA1310_85150} {RNA815_45687} | |
10. | MligTC455_23786 | 47 | 0.98 | Mlig455_021109 | Neo: - Age: Up-Up-Down |
BRSK1 | 1 | - | - | - | 1.000 | - | - | Mlig455_021109 {REF} {Length: 3593} {Pfam: Protein kinase domain [PF00069.27, score=35.3]} {Human: ENSG00000160469, BRSK1, BR serine/threonine kinase 1, [Score=124, Expect=2e-29]; ENSG00000174672, BRSK2, BR serine/threonine kinase 2, [Score=124, Expect=1e-29]} {Mouse: ENSMUSG00000053046, Brsk2, BR serine/threonine kinase 2, [RH, Score=124, Expect=3e-30]} {Dmel: FBgn0036544, sff, sugar-free frosting, [Score=148, Expect=1e-37]} {Celegans: WBGene00004719, sad-1, Serine/threonine kinase SAD-1, [Score=158, Expect=2e-41]} {Smed: dd_Smed_v6_5328_1_3, dd_Smed_v6_5328_1_3, [Score=187, Expect=3e-52]} {RNA1509_20961} {RNA1310_15822} {RNA815_12388} |
11. | MligTC455_40341 | 106 | 2.2 | Mlig455_060207, Mlig455_070456 | Neo: - Age: Down-Down-Up Region-enriched R2: 6.703/0.00648 |
NPY2R | 1 | - | - | - | 1.000 | - | - | Mlig455_060207 {REF} {Length: 3062} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=177.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=47.3]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=29.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.6]} {Human: ENSG00000185149, NPY2R, neuropeptide Y receptor Y2, [RH, Score=178, Expect=9e-51]} {Mouse: ENSMUSG00000028004, Npy2r, neuropeptide Y receptor Y2, [RH, Score=176, Expect=3e-50]; ENSMUSG00000031932, Gpr83, G protein-coupled receptor 83, [RH, Score=176, Expect=1e-49]} {Dmel: FBgn0036934, sNPF-R, short neuropeptide F receptor, [Score=245, Expect=4e-74]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [RH, Score=215, Expect=5e-65]} {Smed: dd_Smed_v6_15335_0_1, dd_Smed_v6_15335_0_1, [RH, Score=313, Expect=2e-103]} {RNA1310_18147.1} {RNA815_7986} Mlig455_070456 {REF} {Length: 3569} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=176.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=29.2]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.3]} {Human: ENSG00000185149, NPY2R, neuropeptide Y receptor Y2, [RH, Score=177, Expect=8e-50]} {Mouse: ENSMUSG00000028004, Npy2r, neuropeptide Y receptor Y2, [RH, Score=175, Expect=3e-49]; ENSMUSG00000031932, Gpr83, G protein-coupled receptor 83, [RH, Score=174, Expect=2e-48]} {Dmel: FBgn0035610, Lkr, Leucokinin receptor, [RH, Score=166, Expect=2e-44]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [Score=215, Expect=4e-64]} {Smed: dd_Smed_v6_15335_0_1, dd_Smed_v6_15335_0_1, [RH, Score=315, Expect=8e-103]} {RNA1310_18147.1} {RNA815_7986} |
12. | MligTC455_15694 | 54 | 1.13 | Mlig455_026426, Mlig455_026456 | Neo: - Age: - Region-enriched R2: 6.151/0.00957 |
SSTR1 | 0.999 | - | - | - | 0.999 | - | - | Mlig455_026426 {REF} {Length: 2191} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=134.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=28.7]; Olfactory receptor [PF13853.8, score=26.6]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.2]} {Human: ENSG00000139874, SSTR1, somatostatin receptor 1, [Score=138, Expect=3e-36]} {Mouse: ENSMUSG00000035431, Sstr1, somatostatin receptor 1, [Score=140, Expect=6e-37]; ENSMUSG00000037014, Sstr4, somatostatin receptor 4, [Score=135, Expect=4e-35]} {Dmel: FBgn0036790, AstC-R1, Allatostatin C receptor 1, [Score=124, Expect=5e-31]} {Celegans: WBGene00013782, npr-32, NeuroPeptide Receptor family, [Score=111, Expect=1e-26]} {Smed: dd_Smed_v6_16055_0_1, dd_Smed_v6_16055_0_1, [Score=128, Expect=2e-33]} {RNA1310_38996} {RNA815_25059} Mlig455_026456 {REF} {Length: 2423} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=134.5]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=28.9]; Olfactory receptor [PF13853.8, score=26.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.3]} {Human: ENSG00000139874, SSTR1, somatostatin receptor 1, [Score=138, Expect=3e-36]} {Mouse: ENSMUSG00000035431, Sstr1, somatostatin receptor 1, [Score=140, Expect=5e-37]; ENSMUSG00000037014, Sstr4, somatostatin receptor 4, [Score=135, Expect=3e-35]} {Dmel: FBgn0036790, AstC-R1, Allatostatin C receptor 1, [Score=124, Expect=7e-31]} {Celegans: WBGene00013782, npr-32, NeuroPeptide Receptor family, [Score=110, Expect=2e-26]} {Smed: dd_Smed_v6_16055_0_1, dd_Smed_v6_16055_0_1, [Score=128, Expect=1e-33]} {RNA1310_38996} {RNA815_25059} |
13. | MligTC455_20177 | 14 | 0.28 | Mlig455_022122 | Neo: - Age: - |
0.999 | - | - | - | 0.999 | - | - | Mlig455_022122 {REF} {Length: 775} {Pfam: LegC3 N-terminal coiled-coil domain [PF18654.3, score=20.6]} {RNA1310_88410} | |
14. | MligTC455_11631 | 21 | 0.44 | Mlig455_004595 | Neo: - Age: - |
0.998 | - | - | - | 0.998 | - | - | Mlig455_004595 {REF} {Length: 2076} {Mouse: ENSMUSG00000026649, Cfap126, cilia and flagella associated protein 126, [Score=47.0, Expect=1e-05]} {RNA1310_44557.1} {RNA815_31853} | |
15. | MligTC455_13098 | 19 | 0.4 | Mlig455_020992 | Neo: - Age: - |
C1GALT1 | 0.998 | - | - | - | 0.998 | - | - | Mlig455_020992 {REF} {Length: 1108} {Pfam: Galactosyltransferase [PF01762.23, score=27.6]} {Human: ENSG00000106392, C1GALT1, core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1, [Score=160, Expect=3e-46]} {Mouse: ENSMUSG00000042460, C1galt1, core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1, [Score=162, Expect=1e-46]} {Dmel: FBgn0032078, C1GalTA, Core 1 Galactosyltransferase A, [Score=138, Expect=8e-38]} {Celegans: WBGene00008019, C38H2.2, Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1, [Score=165, Expect=4e-48]} {Smed: dd_Smed_v6_4310_0_1, dd_Smed_v6_4310_0_1, [Score=185, Expect=3e-56]} {RNA1310_125941} |
16. | MligTC455_19679 | 66 | 1.38 | Mlig455_028164 | Neo: - Age: - Region-enriched R2: 5.194/0.00256 |
SLC7A11 | 0.998 | - | - | - | 0.998 | - | - | Mlig455_028164 {REF} {Length: 3562} {TRANSSPLICED} {Pfam: Amino acid permease [PF13520.8, score=187.6]; Amino acid permease [PF00324.23, score=95.8]} {Human: ENSG00000151012, SLC7A11, solute carrier family 7 member 11, [RH, Score=350, Expect=1e-115]} {Mouse: ENSMUSG00000027737, Slc7a11, solute carrier family 7 (cationic amino acid transporter, y+ system), member 11, [Score=370, Expect=2e-123]} {Dmel: FBgn0002778, mnd, minidiscs, [RH, Score=379, Expect=5e-127]} {Celegans: WBGene00000004, aat-3, Amino Acid Transporter, [Score=331, Expect=2e-108]} {Smed: dd_Smed_v6_4211_0_1, dd_Smed_v6_4211_0_1, [Score=465, Expect=3e-160]} {RNA1310_31710.1} {RNA815_14153} |
17. | MligTC455_34815 | 30 | 0.63 | Mlig455_020979 | Neo: - Age: - |
0.998 | - | - | - | 0.998 | - | - | Mlig455_020979 {REF} {Length: 1394} {RNA1310_37266} | |
18. | MligTC455_14444 | 9 | 0.19 | Mlig455_033479 | Neo: - Age: - |
CHRNB3 | 0.995 | - | - | - | 0.995 | - | - | Mlig455_033479 {REF} {Length: 1770} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=103.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=32.7]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=114, Expect=3e-27]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=109, Expect=6e-26]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=104, Expect=4e-24]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=97.4, Expect=1e-21]} {Celegans: WBGene00011356, lgc-15, Ligand-Gated ion Channel, [RH, Score=95.1, Expect=2e-21]} {Smed: dd_Smed_v6_62726_0_1, dd_Smed_v6_62726_0_1, [Score=153, Expect=1e-42]} {RNA1310_44183.1} {RNA815_32188} |
19. | MligTC455_17392 | 11 | 0.23 | Mlig455_001448 | Neo: - Age: - |
0.995 | - | - | - | 0.995 | - | - | Mlig455_001448 {REF} {Length: 2293} {TRANSSPLICED} {RNA1509_28752} {RNA1310_59892} {RNA815_54202} | |
20. | MligTC455_26653 | 3263 | 67.97 | Mlig455_049144, Mlig455_049196 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.518 Region-specific R3: 7.699 Region-enriched R3: 6.693/0.00000 |
0.994 | - | - | - | 0.994 | - | - | Mlig455_049144 {REF} {Length: 862} {Pfam: CUB domain [PF00431.22, score=21.5]} {RNA1509_5316} {RNA1310_45244} {RNA815_23025} Mlig455_049196 {REF} {Length: 3464} {Pfam: CUB domain [PF00431.22, score=21.5]} {RNA1509_23994, RNA1509_5316} {RNA1310_45244, RNA1509_23994, RNA1509_5316} {RNA1509_23994, RNA1509_5316, RNA815_23025} |
|
21. | MligTC455_31462 | 23 | 0.48 | Mlig455_000844 | Neo: - Age: - |
0.994 | - | - | - | 0.994 | - | - | Mlig455_000844 {REF} {Length: 2564} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=39.1]} {Smed: dd_Smed_v6_12148_0_2, dd_Smed_v6_12148_0_2, [Score=81.6, Expect=5e-18]} {RNA1509_6604} {RNA1310_43619} {RNA815_6128.2} | |
22. | MligTC455_31463 | 20 | 0.42 | Mlig455_057169 | Neo: - Age: - |
0.994 | - | - | - | 0.994 | - | - | Mlig455_057169 {REF} {Length: 1647} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=39.0]} {Smed: dd_Smed_v6_12148_0_2, dd_Smed_v6_12148_0_2, [Score=82.4, Expect=3e-18]} {RNA1509_6604} {RNA1310_43619} {RNA815_6128.2} | |
23. | MligTC455_22400 | 2410 | 50.2 | Mlig455_049145 | Neo: - Age: logFC(26M/2M)=0.314 Region-enriched R3: 6.393/0.00000 |
0.993 | - | - | - | 0.993 | - | - | Mlig455_049145 {REF} {Length: 929} {RNA1509_6763, RNA1509_7997} {RNA1310_46088, RNA1509_6763, RNA1509_7997} {RNA1509_6763, RNA1509_7997, RNA815_22985} | |
24. | MligTC455_51262 | 384 | 7.99 | Mlig455_036989 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.021 Region-enriched R3: 4.958/0.00000 |
0.991 | - | - | - | 0.991 | - | - | Mlig455_036989 {REF} {Length: 1396} {Pfam: Universal stress protein family [PF00582.28, score=85.7]} {Smed: dd_Smed_v6_402_1_1, dd_Smed_v6_402_1_1, [Score=97.4, Expect=8e-26]} {RNA1310_30400} {RNA815_28361} | |
25. | MligTC455_10599 | 140 | 2.91 | Mlig455_000565, Mlig455_030365, Mlig455_030412 | Neo: - Age: logFC(26M/2M)=-0.762 |
GRIK3 | 0.989 | - | - | - | 0.989 | - | - | Mlig455_000565 {REF} {Length: 2846} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=72.0]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=56.1]; Ligand-gated ion channel [PF00060.28, score=44.5]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=145, Expect=3e-35]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=142, Expect=3e-34]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=141, Expect=5e-34]; ENSG00000105737, GRIK5, glutamate ionotropic receptor kainate type subunit 5, [Score=139, Expect=3e-33]} {Mouse: ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=144, Expect=5e-35]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=143, Expect=1e-34]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=140, Expect=9e-34]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=139, Expect=2e-33]; ENSMUSG00000003378, Grik5, glutamate receptor, ionotropic, kainate 5 (gamma 2), [Score=138, Expect=5e-33]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=138, Expect=4e-33]} {Dmel: FBgn0039916, Ekar, Eye-enriched kainate receptor, [Score=130, Expect=1e-30]} {Celegans: WBGene00001613, glr-2, Glutamate receptor 2, [Score=135, Expect=3e-32]} {Smed: dd_Smed_v6_14655_0_1, dd_Smed_v6_14655_0_1, [Score=154, Expect=2e-38]} {RNA1509_59839} {RNA1310_4586} {RNA815_2154.1} Mlig455_030365 {REF} {Length: 2765} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=72.6]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=57.7]; Ligand-gated ion channel [PF00060.28, score=43.6]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=144, Expect=6e-35]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=140, Expect=2e-33]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=138, Expect=7e-33]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=138, Expect=7e-33]; ENSG00000105737, GRIK5, glutamate ionotropic receptor kainate type subunit 5, [Score=137, Expect=2e-32]} {Mouse: ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=142, Expect=2e-34]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=142, Expect=2e-34]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=138, Expect=4e-33]; ENSMUSG00000003378, Grik5, glutamate receptor, ionotropic, kainate 5 (gamma 2), [Score=136, Expect=2e-32]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=136, Expect=2e-32]} {Dmel: FBgn0039916, Ekar, Eye-enriched kainate receptor, [Score=130, Expect=6e-31]} {Celegans: WBGene00001613, glr-2, Glutamate receptor 2, [Score=131, Expect=3e-31]} {Smed: dd_Smed_v6_14655_0_1, dd_Smed_v6_14655_0_1, [Score=155, Expect=7e-39]} {RNA1509_59839} {RNA1310_4586} {RNA815_2154.1} Mlig455_030412 {REF} {Length: 2615} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=72.2]; Ligand-gated ion channel [PF00060.28, score=45.1]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=36.1]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=125, Expect=6e-29]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=122, Expect=6e-28]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=121, Expect=1e-27]} {Mouse: ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=125, Expect=4e-29]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=124, Expect=6e-29]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=120, Expect=2e-27]} {Dmel: FBgn0026255, clumsy, [Score=117, Expect=9e-27]} {Celegans: WBGene00001613, glr-2, Glutamate receptor 2, [Score=117, Expect=7e-27]} {Smed: dd_Smed_v6_14655_0_1, dd_Smed_v6_14655_0_1, [Score=135, Expect=1e-32]} {RNA1509_59839} {RNA1310_4586} {RNA815_2154.1} |
26. | MligTC455_09018 | 292 | 6.08 | Mlig455_014490, Mlig455_014509, Mlig455_054440 | Neo: - Age: - |
0.988 | - | - | 0.988 | - | - | - | Mlig455_014490 {REF} {Length: 2182} {RNA1509_36919} {RNA1310_69131} {RNA815_36781} Mlig455_014509 {REF} {Length: 2307} {RNA1509_36919} {RNA1310_69131} {RNA815_36781} Mlig455_054440 {REF} {Length: 2592} {NoTransDecoderORF} {RNA1509_36919} {RNA1310_69131} {RNA815_36781} |
|
27. | MligTC455_12377 | 14 | 0.29 | Mlig455_022784 | Neo: - Age: - |
0.987 | - | 0.987 | - | - | - | - | Mlig455_022784 {REF} {Length: 1064} {RNA1310_136157} | |
28. | MligTC455_47733 | 81 | 1.69 | Mlig455_044125 | Neo: - Age: logFC(26M/2M)=0.424 Region-enriched R6: 4.050/0.00363 Regeneration-downregulated R6: -6.610 Regeneration-depleted R6: -6.610 |
0.987 | - | - | - | 0.987 | - | - | Mlig455_044125 {REF} {Length: 4219} {Pfam: Peptidase family M13 [PF05649.15, score=42.8]} {RNA1310_43623} {RNA815_36140} | |
29. | MligTC455_51260 | 90 | 1.88 | Mlig455_009349 | Neo: - Age: - |
0.987 | - | - | - | 0.987 | - | - | Mlig455_009349 {REF} {Length: 1657} {Pfam: Universal stress protein family [PF00582.28, score=83.5]} {Smed: dd_Smed_v6_402_1_1, dd_Smed_v6_402_1_1, [Score=97.8, Expect=2e-24]} {RNA1310_30400} {RNA815_28361} | |
30. | MligTC455_52122 | 1435 | 29.9 | Mlig455_035226, Mlig455_035273 | Neo: - Age: - Region-enriched R3: 3.936/0.00000 |
0.987 | - | - | - | 0.987 | - | - | Mlig455_035226 {REF} {Length: 725} {TRANSSPLICED} {RNA1509_39421} {RNA1310_8553.2, RNA1509_39421} {RNA1509_39421, RNA815_2974.1} Mlig455_035273 {REF} {Length: 1422} {RNA1509_24257, RNA1509_39421} {RNA1310_8553.2, RNA1509_24257} {RNA1509_24257, RNA815_2974.1} |
|
31. | MligTC455_52527 | 28 | 0.58 | Mlig455_025836 | Neo: - Age: - |
FLVCR2 | 0.986 | - | 0.986 | - | - | - | - | Mlig455_025836 {REF} {Length: 2177} {TRANSSPLICED} {Pfam: Major Facilitator Superfamily [PF07690.18, score=81.4]; Sugar (and other) transporter [PF00083.26, score=18.7]} {Human: ENSG00000119686, FLVCR2, feline leukemia virus subgroup C cellular receptor family member 2, [RH, Score=364, Expect=5e-119]} {Mouse: ENSMUSG00000034258, Flvcr2, feline leukemia virus subgroup C cellular receptor 2, [RH, Score=367, Expect=3e-120]} {Dmel: FBgn0033196, CG1358, [RH, Score=350, Expect=1e-114]} {Celegans: WBGene00015632, C09D4.1, Uncharacterized MFS-type transporter C09D4.1, [RH, Score=358, Expect=1e-116]} {Smed: dd_Smed_v6_7578_0_1, dd_Smed_v6_7578_0_1, [Score=335, Expect=3e-109]} {RNA1509_31725} {RNA1310_8852.1} {RNA815_14234} |
32. | MligTC455_13395 | 18 | 0.38 | Mlig455_061750 | Neo: - Age: - |
QRFPR | 0.985 | - | 0.985 | - | - | - | - | Mlig455_061750 {REF} {Length: 1579} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=107.1]} {Human: ENSG00000186867, QRFPR, pyroglutamylated RFamide peptide receptor, [Score=99.8, Expect=2e-22]} {Mouse: ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=92.8, Expect=2e-20]} {Dmel: FBgn0050106, CCHa1-R, CCHamide-1 receptor, [Score=78.6, Expect=1e-15]} {Celegans: WBGene00021983, npr-5, NeuroPeptide Receptor family, [Score=77.4, Expect=2e-15]} {Smed: dd_Smed_v6_14520_0_1, dd_Smed_v6_14520_0_1, [Score=73.9, Expect=2e-14]} {RNA1310_103173} {RNA815_39338} |
33. | MligTC455_08191 | 8 | 0.17 | Mlig455_045635, Mlig455_045681, Mlig455_045683, Mlig455_045693 | Neo: - Age: - |
0.984 | - | - | - | 0.984 | - | - | Mlig455_045635 {REF} {Length: 2654} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=53.0]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=47.3]} {Dmel: FBgn0029768, SPR, Sex peptide receptor, [Score=52.0, Expect=1e-06]} {Celegans: WBGene00010986, sprr-1, Sex Peptide Receptor (Drosophila) Related, [Score=66.6, Expect=3e-11]} {Smed: dd_Smed_v6_11997_0_1, dd_Smed_v6_11997_0_1, [RH, Score=157, Expect=7e-42]} {RNA1310_27374} {RNA815_31428} Mlig455_045681 {REF} {Length: 666} {NoTransDecoderORF} {RNA1310_127829} {RNA815_56627} Mlig455_045683 {REF} {Length: 2634} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=52.4]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=48.0]} {Dmel: FBgn0029768, SPR, Sex peptide receptor, [Score=50.4, Expect=5e-06]} {Celegans: WBGene00010986, sprr-1, Sex Peptide Receptor (Drosophila) Related, [Score=67.0, Expect=3e-11]} {Smed: dd_Smed_v6_11997_0_1, dd_Smed_v6_11997_0_1, [RH, Score=157, Expect=1e-41]} {RNA1310_27374} {RNA815_31428} Mlig455_045693 {REF} {Length: 4107} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=52.4]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=47.8]} {Celegans: WBGene00010986, sprr-1, Sex Peptide Receptor (Drosophila) Related, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_11997_0_1, dd_Smed_v6_11997_0_1, [RH, Score=157, Expect=9e-42]} {RNA1310_27374} {RNA815_31428} |
|
34. | MligTC455_15022 | 16 | 0.33 | Mlig455_040949 | Neo: - Age: - |
PRKAR2B | 0.984 | - | - | 0.984 | - | - | - | Mlig455_040949 {REF} {Length: 1526} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=128.5]} {Human: ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=191, Expect=3e-57]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=191, Expect=3e-57]; ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=190, Expect=5e-57]} {Mouse: ENSMUSG00000002997, Prkar2b, protein kinase, cAMP dependent regulatory, type II beta, [Score=189, Expect=1e-56]; ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=188, Expect=2e-56]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=217, Expect=5e-68]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=130, Expect=3e-35]} {Smed: dd_Smed_v6_2902_0_1, dd_Smed_v6_2902_0_1, [Score=187, Expect=8e-57]} {RNA1310_91044} {RNA815_60658} |
35. | MligTC455_09416 | 15 | 0.32 | Mlig455_025505, Mlig455_025526 | Neo: - Age: - |
HRH1 | 0.983 | - | 0.983 | - | - | - | - | Mlig455_025505 {REF} {Length: 1843} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=122.8]} {Human: ENSG00000196639, HRH1, histamine receptor H1, [Score=131, Expect=4e-34]} {Mouse: ENSMUSG00000053004, Hrh1, histamine receptor H1, [Score=127, Expect=9e-33]} {Dmel: FBgn0000037, mAChR-A, muscarinic Acetylcholine Receptor, A-type, [Score=113, Expect=2e-27]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=102, Expect=4e-24]} {Smed: dd_Smed_v6_15040_0_1, dd_Smed_v6_15040_0_1, [Score=99.4, Expect=4e-23]} {RNA1509_53354} {RNA1310_79526} {RNA815_31150} Mlig455_025526 {REF} {Length: 2045} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=247.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=30.1]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.8]; Olfactory receptor [PF13853.8, score=23.3]} {Human: ENSG00000196639, HRH1, histamine receptor H1, [RH, Score=264, Expect=2e-82]} {Mouse: ENSMUSG00000053004, Hrh1, histamine receptor H1, [RH, Score=264, Expect=2e-82]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=192, Expect=2e-54]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=187, Expect=4e-53]} {Smed: dd_Smed_v6_48706_0_1, dd_Smed_v6_48706_0_1, [Score=189, Expect=2e-55]} {RNA1509_53354} {RNA1310_79526} {RNA815_31150} |
36. | MligTC455_18943 | 22 | 0.45 | Mlig455_029163, Mlig455_030251 | Neo: - Age: - |
WNT2, WNT2B | 0.983 | - | - | - | 0.983 | - | - | Mlig455_029163 {REF} {Length: 1857} {Pfam: wnt family [PF00110.21, score=310.5]} {Human: ENSG00000134245, WNT2B, Wnt family member 2B, [RH, Score=219, Expect=3e-67]; ENSG00000105989, WNT2, Wnt family member 2, [RH, Score=217, Expect=7e-67]; ENSG00000002745, WNT16, Wnt family member 16, [RH, Score=215, Expect=5e-66]; ENSG00000162552, WNT4, Wnt family member 4, [RH, Score=212, Expect=5e-65]; ENSG00000115596, WNT6, Wnt family member 6, [RH, Score=211, Expect=1e-64]} {Mouse: ENSMUSG00000027840, Wnt2b, wingless-type MMTV integration site family, member 2B, [RH, Score=219, Expect=3e-67]; ENSMUSG00000029671, Wnt16, wingless-type MMTV integration site family, member 16, [RH, Score=217, Expect=4e-67]; ENSMUSG00000010797, Wnt2, wingless-type MMTV integration site family, member 2, [RH, Score=216, Expect=8e-67]; ENSMUSG00000033227, Wnt6, wingless-type MMTV integration site family, member 6, [RH, Score=215, Expect=3e-66]; ENSMUSG00000036856, Wnt4, wingless-type MMTV integration site family, member 4, [RH, Score=214, Expect=8e-66]} {Dmel: FBgn0031902, Wnt6, Wnt oncogene analog 6, [RH, Score=178, Expect=2e-51]} {Celegans: WBGene00001188, egl-20, Wnt homolog, [RH, Score=217, Expect=8e-67]} {Smed: dd_Smed_v6_14865_0_1, dd_Smed_v6_14865_0_1, [RH, Score=190, Expect=8e-57]} {RNA1310_39391} {RNA815_58383} Mlig455_030251 {REF} {Length: 1574} {Pfam: wnt family [PF00110.21, score=280.5]} {Human: ENSG00000105989, WNT2, Wnt family member 2, [RH, Score=207, Expect=2e-62]} {Mouse: ENSMUSG00000010797, Wnt2, wingless-type MMTV integration site family, member 2, [RH, Score=208, Expect=8e-63]} {Dmel: FBgn0031902, Wnt6, Wnt oncogene analog 6, [RH, Score=178, Expect=7e-51]} {Celegans: WBGene00000858, cwn-2, [Score=201, Expect=1e-60]} {Smed: dd_Smed_v6_14865_0_1, dd_Smed_v6_14865_0_1, [RH, Score=186, Expect=9e-55]} {RNA1310_39214} {RNA815_58383} |
37. | MligTC455_22399 | 3614 | 75.29 | Mlig455_049143 | Neo: - Age: Down-Down-Up Region-enriched R3: 6.448/0.00000 |
0.983 | - | - | - | 0.983 | - | - | Mlig455_049143 {REF} {Length: 1035} {RNA1509_3861, RNA1509_6763} {RNA1310_46088, RNA1509_3861} {RNA1509_3861, RNA815_22985} | |
38. | MligTC455_27151 | 2425 | 50.53 | Mlig455_010141 | Neo: Int S/G2/M Age: logFC(26M/2M)=-1.620 Region-enriched R3: 6.747/0.00000 |
0.983 | - | - | - | 0.983 | - | - | Mlig455_010141 {REF} {Length: 873} {RNA1509_6591} {RNA1310_101555} {RNA815_33850} | |
39. | MligTC455_36996 | 285 | 5.93 | Mlig455_050334 | Neo: - Age: - Region-enriched R2: 6.300/0.00168 |
CACNA1C | 0.983 | - | - | - | 0.983 | - | - | Mlig455_050334 {REF} {Length: 4859} {Pfam: Ion transport protein [PF00520.33, score=618.4]; FAM176 family [PF14851.8, score=22.7]; Polycystin cation channel [PF08016.14, score=21.8]} {Human: ENSG00000285479, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [Score=1126, Expect=0.0]; ENSG00000151067, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [Score=1126, Expect=0.0]; ENSG00000081248, CACNA1S, calcium voltage-gated channel subunit alpha1 S, [Score=1110, Expect=0.0]; ENSG00000157388, CACNA1D, calcium voltage-gated channel subunit alpha1 D, [Score=1073, Expect=0.0]} {Mouse: ENSMUSG00000051331, Cacna1c, calcium channel, voltage-dependent, L type, alpha 1C subunit, [Score=1125, Expect=0.0]; ENSMUSG00000026407, Cacna1s, calcium channel, voltage-dependent, L type, alpha 1S subunit, [Score=1100, Expect=0.0]} {Dmel: FBgn0001991, Ca-alpha1D, Ca[2+]-channel protein alpha[[1]] subunit D, [Score=1219, Expect=0.0]} {Celegans: WBGene00006742, unc-2, High voltage activated calcium channel alpha-1 subunit, [Score=785, Expect=0.0]} {Smed: dd_Smed_v6_8899_0_18, dd_Smed_v6_8899_0_18, [Score=1230, Expect=0.0]} {RNA1509_10231} {RNA1310_369.1, RNA1509_10231} {RNA1509_10231, RNA815_298.1} |
40. | MligTC455_12886 | 7 | 0.15 | Mlig455_062770 | Neo: - Age: - |
0.982 | - | 0.982 | - | - | - | - | Mlig455_062770 {REF} {Length: 486} {RNA1310_94667} | |
41. | MligTC455_43137 | 118 | 2.46 | Mlig455_043159 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.878 Region-enriched R2: 5.988/0.00166 |
0.981 | - | 0.981 | - | - | - | - | Mlig455_043159 {REF} {Length: 1651} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=25.7]} {RNA1509_48871} {RNA1310_23692, RNA1509_48871} {RNA1509_48871, RNA815_11317} | |
42. | MligTC455_49303 | 64 | 1.33 | Mlig455_058897 | Neo: - Age: - |
SALL3 | 0.981 | - | 0.981 | - | - | - | - | Mlig455_058897 {REF} {Length: 4598} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=70.9]; C2H2-type zinc finger [PF13894.8, score=55.8]; Zinc-finger double domain [PF13465.8, score=55.4]; Zinc-finger of C2H2 type [PF12874.9, score=45.8]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=39.1]} {Human: ENSG00000256463, SALL3, spalt like transcription factor 3, [Score=92.4, Expect=3e-18]; ENSG00000277015, SALL3, spalt like transcription factor 3, [Score=92.4, Expect=3e-18]; ENSG00000263310, SALL3, spalt like transcription factor 3, [Score=92.4, Expect=3e-18]; ENSG00000101115, SALL4, spalt like transcription factor 4, [Score=91.3, Expect=5e-18]; ENSG00000130856, ZNF236, zinc finger protein 236, [Score=90.9, Expect=1e-17]; ENSG00000103449, SALL1, spalt like transcription factor 1, [Score=90.1, Expect=2e-17]} {Mouse: ENSMUSG00000024565, Sall3, spalt like transcription factor 3, [Score=92.0, Expect=2e-18]; ENSMUSG00000027547, Sall4, spalt like transcription factor 4, [Score=91.7, Expect=3e-18]; ENSMUSG00000031665, Sall1, spalt like transcription factor 1, [Score=90.1, Expect=1e-17]} {Dmel: FBgn0261648, salm, spalt major, [RH, Score=97.4, Expect=5e-20]} {Celegans: WBGene00004773, sem-4, SEM-4 long form, [RH, Score=97.4, Expect=2e-20]} {Smed: dd_Smed_v6_14176_0_1, dd_Smed_v6_14176_0_1, [RH, Score=121, Expect=2e-28]} {RNA1310_43057} {RNA815_29425} |
43. | MligTC455_08098 | 15 | 0.31 | Mlig455_029099 | Neo: - Age: - Region-enriched R2: 8.013/0.00338 |
0.98 | - | 0.980 | - | - | - | - | Mlig455_029099 {REF} {Length: 1334} {RNA1310_58776} {RNA815_46110} | |
44. | MligTC455_08408 | 41 | 0.86 | Mlig455_043171 | Neo: - Age: Up-Down-Down |
0.98 | - | 0.980 | - | - | - | - | Mlig455_043171 {REF} {Length: 1568} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.4]} {RNA1310_47844} {RNA815_49360} | |
45. | MligTC455_08763 | 20 | 0.41 | Mlig455_061186 | Neo: - Age: - |
0.98 | - | 0.980 | - | - | - | - | Mlig455_061186 {REF} {Length: 1077} {Smed: dd_Smed_v6_13791_0_1, dd_Smed_v6_13791_0_1, [Score=96.3, Expect=3e-24]} {RNA1310_122132} | |
46. | MligTC455_09874 | 31 | 0.65 | Mlig455_045071 | Neo: - Age: - |
DOC2A | 0.98 | - | 0.980 | - | - | - | - | Mlig455_045071 {REF} {Length: 1760} {Pfam: C2 domain [PF00168.32, score=55.9]} {Human: ENSG00000149927, DOC2A, double C2 domain alpha, [Score=55.8, Expect=7e-08]} {Mouse: ENSMUSG00000052301, Doc2a, double C2, alpha, [Score=55.5, Expect=7e-08]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=70.5, Expect=2e-13]} {Smed: dd_Smed_v6_16731_0_1, dd_Smed_v6_16731_0_1, [Score=112, Expect=7e-27]} {RNA1310_36283} {RNA815_40844} |
47. | MligTC455_10227 | 76 | 1.59 | Mlig455_023507, Mlig455_023516, Mlig455_023551 | Neo: - Age: - |
0.98 | - | 0.980 | - | - | - | - | Mlig455_023507 {REF} {Length: 1545} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.8]} {RNA1310_22533.3} {RNA815_23050} Mlig455_023516 {REF} {Length: 1641} {RNA1310_22533.3} {RNA815_23050} Mlig455_023551 {REF} {Length: 1638} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_22533.3} {RNA815_26724.1} |
|
48. | MligTC455_10229 | 24 | 0.49 | Mlig455_023615 | Neo: - Age: - |
0.98 | - | 0.980 | - | - | - | - | Mlig455_023615 {REF} {Length: 1635} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_22533.3} {RNA815_23050} | |
49. | MligTC455_10810 | 6 | 0.12 | Mlig455_069505 | Neo: - Age: - |
0.98 | - | 0.980 | - | - | - | - | Mlig455_069505 {REF} {Length: 376} {NoTransDecoderORF} {RNA1310_40761} | |
50. | MligTC455_11661 | 4 | 0.08 | Mlig455_019371, Mlig455_059103 | Neo: - Age: - |
0.98 | - | 0.980 | - | - | - | - | Mlig455_019371 {REF} {Length: 67} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_39490} {RNA1310_101865} {RNA815_41733} Mlig455_059103 {REF} {Length: 67} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_39490} {RNA1310_101865} {RNA815_41733} |
|
51. | MligTC455_12116 | 106 | 2.2 | Mlig455_004661, Mlig455_004728 | Neo: - Age: Up-Up-Down |
0.98 | - | 0.980 | - | - | - | - | Mlig455_004661 {REF} {Length: 3441} {RNA1509_48407} {RNA1310_2938.1} {RNA815_14343.2} Mlig455_004728 {REF} {Length: 2670} {RNA1509_48407} {RNA1310_45267.1, RNA1509_48407} {RNA1509_48407, RNA815_58661} |
|
52. | MligTC455_13049 | 53 | 1.11 | Mlig455_029230, Mlig455_029252, Mlig455_035639, Mlig455_035735 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.077/0.00215 |
HTR2A | 0.98 | - | 0.980 | - | - | - | - | Mlig455_029230 {REF} {Length: 2756} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=149.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.0]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.6]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=24.1]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=19.2]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=142, Expect=3e-37]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=141, Expect=5e-37]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=138, Expect=8e-36]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=131, Expect=1e-32]} {Celegans: WBGene00004776, ser-1, SERotonin/octopamine receptor family; Serotonin receptor, [Score=120, Expect=2e-29]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=281, Expect=8e-90]} {RNA1310_91864} Mlig455_029252 {REF} {Length: 2844} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=188.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.8]; Spt20 family [PF12090.10, score=21.4]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=144, Expect=2e-36]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=142, Expect=4e-36]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=140, Expect=1e-35]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=136, Expect=2e-33]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=157, Expect=2e-41]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=336, Expect=4e-108]} {RNA1310_91864} Mlig455_035639 {REF} {Length: 2811} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=182.5]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.7]; Spt20 family [PF12090.10, score=24.8]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=144, Expect=2e-36]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=143, Expect=3e-36]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=141, Expect=1e-35]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=133, Expect=6e-32]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=156, Expect=5e-41]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=284, Expect=3e-88]} {RNA1310_91864} Mlig455_035735 {REF} {Length: 1469} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=140.9]; Spt20 family [PF12090.10, score=23.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=18.8]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=97.1, Expect=3e-21]; ENSG00000147246, HTR2C, 5-hydroxytryptamine receptor 2C, [Score=95.1, Expect=2e-20]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=95.5, Expect=1e-20]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=93.2, Expect=6e-20]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=89.0, Expect=2e-18]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=115, Expect=1e-27]} {Smed: dd_Smed_v6_31134_0_1, dd_Smed_v6_31134_0_1, [Score=249, Expect=4e-77]} {RNA1310_91864} |
53. | MligTC455_16248 | 132 | 2.74 | Mlig455_038325, Mlig455_050222, Mlig455_050231 | Neo: - Age: - |
CHRNA3 | 0.98 | - | 0.980 | - | - | - | - | Mlig455_038325 {REF} {Length: 1078} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=200.0]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=192, Expect=4e-57]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=194, Expect=7e-58]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=190, Expect=1e-56]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=206, Expect=1e-62]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=186, Expect=4e-55]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=216, Expect=5e-67]} {RNA1310_44575} {RNA815_22042} Mlig455_050222 {REF} {Length: 2164} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=202.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=197.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=348, Expect=5e-114]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=335, Expect=4e-109]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=348, Expect=2e-114]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=343, Expect=2e-112]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=335, Expect=5e-109]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=397, Expect=1e-133]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=338, Expect=2e-110]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=489, Expect=5e-170]} {RNA1310_44575} {RNA815_22042} Mlig455_050231 {REF} {Length: 2219} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=203.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=143.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=304, Expect=5e-99]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=299, Expect=8e-97]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=293, Expect=2e-94]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=290, Expect=7e-92]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=302, Expect=3e-98]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=296, Expect=3e-96]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=291, Expect=5e-94]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=352, Expect=8e-117]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=303, Expect=5e-99]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=424, Expect=2e-146]} {RNA1310_44575} {RNA815_22042} |
54. | MligTC455_21684 | 5 | 0.11 | Mlig455_014284, Mlig455_014320, Mlig455_014336 | Neo: - Age: logFC(26M/2M)=-0.541 |
HECA | 0.98 | - | 0.980 | - | - | - | - | Mlig455_014284 {REF} {Length: 1986} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=8e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=167, Expect=4e-46]} {RNA1509_12340} {RNA1310_16685} {RNA815_9766} Mlig455_014320 {REF} {Length: 2086} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=8e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=167, Expect=4e-46]} {RNA1509_12340} {RNA1310_16685, RNA1509_12340} {RNA1509_12340, RNA815_9766} Mlig455_014336 {REF} {Length: 2009} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=7e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=166, Expect=6e-46]} {RNA1509_12340} {RNA1310_16685} {RNA815_9766} |
55. | MligTC455_26801 | 7 | 0.14 | Mlig455_024981 | Neo: - Age: - |
0.98 | - | 0.980 | - | - | - | - | Mlig455_024981 {REF} {Length: 847} {RNA1310_42506} {RNA815_41145} | |
56. | MligTC455_36567 | 18 | 0.37 | Mlig455_065030 | Neo: - Age: - |
0.98 | - | 0.980 | - | - | - | - | Mlig455_065030 {REF} {Length: 672} | |
57. | MligTC455_37412 | 95 | 1.98 | Mlig455_036605, Mlig455_036645 | Neo: - Age: - |
ADRA2A | 0.98 | - | 0.980 | - | - | - | - | Mlig455_036605 {REF} {Length: 3015} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.8]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=2e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=5e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=64.7, Expect=1e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=7e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=5e-35]} {RNA1310_57451} {RNA815_47300} Mlig455_036645 {REF} {Length: 3203} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.0]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=1e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=4e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=63.2, Expect=4e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=6e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=6e-35]} {RNA1310_57451} {RNA815_47300} |
58. | MligTC455_47927 | 43 | 0.9 | Mlig455_029720 | Neo: - Age: - |
0.98 | - | 0.980 | - | - | - | - | Mlig455_029720 {REF} {Length: 2459} {RNA1509_35671} {RNA1310_75812} {RNA815_33002} | |
59. | MligTC455_47997 | 36 | 0.75 | Mlig455_053262, Mlig455_065031 | Neo: - Age: - |
0.98 | - | 0.980 | - | - | - | - | Mlig455_053262 {REF} {Length: 927} {RNA1310_55950} {RNA815_42062.2} Mlig455_065031 {REF} {Length: 926} {RNA1310_55950} {RNA815_42062.2} |
|
60. | MligTC455_08096 | 18 | 0.37 | Mlig455_006571 | Neo: - Age: - |
0.979 | - | - | - | 0.979 | - | - | Mlig455_006571 {REF} {Length: 1500} {NoTransDecoderORF} {RNA1509_37481} {RNA1310_1635.1} {RNA815_50336} | |
61. | MligTC455_09127 | 11 | 0.24 | Mlig455_051263 | Neo: - Age: - |
TBX2 | 0.979 | - | - | - | 0.979 | - | - | Mlig455_051263 {REF} {Length: 2970} {Pfam: T-box [PF00907.24, score=269.9]} {Human: ENSG00000121068, TBX2, T-box 2, [RH, Score=364, Expect=3e-116]; ENSG00000135111, TBX3, T-box 3, [RH, Score=356, Expect=6e-113]} {Mouse: ENSMUSG00000018604, Tbx3, T-box 3, [RH, Score=365, Expect=1e-116]; ENSMUSG00000000093, Tbx2, T-box 2, [RH, Score=363, Expect=1e-115]} {Dmel: FBgn0000179, bi, bifid, [RH, Score=357, Expect=6e-111]} {Celegans: WBGene00006543, tbx-2, T-box protein 2, [RH, Score=318, Expect=3e-102]} {Smed: dd_Smed_v6_11693_0_1, dd_Smed_v6_11693_0_1, [RH, Score=395, Expect=2e-129]} {RNA1509_33164} {RNA1310_57171} {RNA815_39333} |
62. | MligTC455_53658 | 41 | 0.86 | Mlig455_070698 | Neo: - Age: Up-Down-Down Region-enriched R2: 9.084/0.01491 |
0.979 | - | 0.979 | - | - | - | - | Mlig455_070698 {REF} {Length: 1026} {RNA1509_40972} {RNA1310_35649.1} {RNA815_17004} | |
63. | MligTC455_10226 | 119 | 2.48 | Mlig455_023508, Mlig455_023518, Mlig455_023617 | Neo: - Age: - |
0.978 | - | 0.978 | - | - | - | - | Mlig455_023508 {REF} {Length: 1311} {RNA1310_22533.2} {RNA815_23050} Mlig455_023518 {REF} {Length: 1413} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.5]} {RNA1310_22533.2} {RNA815_23050} Mlig455_023617 {REF} {Length: 1414} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.6]} {RNA1310_22533.2} {RNA815_23050} |
|
64. | MligTC455_10228 | 50 | 1.05 | Mlig455_023553 | Neo: - Age: - |
0.978 | - | 0.978 | - | - | - | - | Mlig455_023553 {REF} {Length: 1195} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.0]} {RNA1310_22533.1} {RNA815_23050} | |
65. | MligTC455_17266 | 62 | 1.3 | Mlig455_043650 | Neo: - Age: - |
0.977 | - | 0.977 | - | - | - | - | Mlig455_043650 {REF} {Length: 2826} {RNA1310_48878} {RNA815_25527} | |
66. | MligTC455_48324 | 1746 | 36.38 | Mlig455_058196 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.604 Region-enriched R3: 5.386/0.00000 |
ZAN | 0.977 | - | - | - | 0.977 | - | - | Mlig455_058196 {REF} {Length: 2399} {Human: ENSG00000146839, ZAN, zonadhesin (gene/pseudogene), [Score=150, Expect=3e-37]} {Mouse: ENSMUSG00000049008, BB014433, expressed sequence BB014433, [Score=67.0, Expect=2e-11]; ENSMUSG00000079173, Zan, zonadhesin, [Score=63.9, Expect=5e-10]} {Dmel: FBgn0034294, Muc55B, Mucin 55B, [Score=109, Expect=6e-25]} {RNA1509_27445} {RNA1310_7841} {RNA815_14882.1} |
67. | MligTC455_17394 | 41 | 0.85 | Mlig455_013077 | Neo: - Age: - |
0.976 | - | 0.976 | - | - | - | - | Mlig455_013077 {REF} {Length: 1066} {RNA1310_66954} {RNA815_27868} | |
68. | MligTC455_49922 | 36 | 0.76 | Mlig455_049338 | Neo: - Age: Down-Down-Up Region-enriched R2: 7.622/0.00496 |
0.976 | - | 0.976 | - | - | - | - | Mlig455_049338 {REF} {Length: 971} {RNA1310_37449} {RNA815_3585} | |
69. | MligTC455_36995 | 217 | 4.52 | Mlig455_040359 | Neo: - Age: Down-Up-Up Region-enriched R2: 6.534/0.00155 |
0.975 | - | - | - | 0.975 | - | - | Mlig455_040359 {REF} {Length: 759} {RNA1509_59636} {RNA1310_6145.1, RNA1509_59636} {RNA1509_59636, RNA815_27612} | |
70. | MligTC455_41443 | 382 | 7.96 | Mlig455_034791, Mlig455_034803 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-1.360 Region-enriched R2: 5.869/0.00205 |
0.975 | - | 0.975 | - | - | - | - | Mlig455_034791 {REF} {Length: 996} {RNA1310_39610.1} {RNA815_26421} Mlig455_034803 {REF} {Length: 1084} {RNA1310_39610.1} {RNA815_26421} |
|
71. | MligTC455_08407 | 22 | 0.46 | Mlig455_043162 | Neo: - Age: - |
0.973 | - | 0.973 | - | - | - | - | Mlig455_043162 {REF} {Length: 1257} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.7]} {RNA1310_58288} {RNA815_55196} | |
72. | MligTC455_18139 | 70 | 1.45 | Mlig455_010809 | Neo: - Age: logFC(26M/2M)=-0.809 Region-enriched R2: 6.868/0.00081 |
TRPC5 | 0.973 | - | 0.973 | - | - | - | - | Mlig455_010809 {REF} {Length: 4442} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.1]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.4]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=740, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=744, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=740, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=694, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1017, Expect=0.0]} {RNA1509_34138} {RNA1310_12839, RNA1509_34138} {RNA1509_34138, RNA815_17637} |
73. | MligTC455_44998 | 385 | 8.02 | Mlig455_041387 | Neo: - Age: logFC(26M/2M)=-0.278 Region-enriched R3: 5.457/0.00000 |
FZD4 | 0.973 | - | - | - | 0.973 | - | - | Mlig455_041387 {REF} {Length: 3889} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=311.1]; Fz domain [PF01392.24, score=97.0]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [Score=416, Expect=2e-138]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [Score=414, Expect=4e-138]} {Dmel: FBgn0001085, fz, frizzled, [Score=284, Expect=2e-87]} {Celegans: WBGene00003006, lin-17, Transmembrane receptor LIN-17, [RH, Score=263, Expect=9e-80]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [Score=435, Expect=8e-146]} {RNA1509_26315} {RNA1310_7806, RNA1509_26315} {RNA1509_26315, RNA815_21086} |
74. | MligTC455_01243 | 37 | 0.77 | Mlig455_055650 | Neo: - Age: - |
0.972 | - | - | - | 0.972 | - | - | Mlig455_055650 {REF} {Length: 625} {Pfam: Universal stress protein family [PF00582.28, score=20.0]} {RNA1310_33871} {RNA815_28361} | |
75. | MligTC455_32563 | 900 | 18.74 | Mlig455_021721 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.879 Region-enriched R2: 4.965/0.00011 |
0.972 | - | - | - | 0.972 | - | - | Mlig455_021721 {REF} {Length: 1079} {RNA1509_570} {RNA1310_40828} {RNA815_5866.1} | |
76. | MligTC455_47736 | 1775 | 36.98 | Mlig455_054650 | Neo: - Age: logFC(26M/2M)=-0.375 Region-enriched R3: 5.288/0.00000 |
0.972 | - | - | - | 0.972 | - | - | Mlig455_054650 {REF} {Length: 1247} {Pfam: Domain of unknown function (DUF4573) [PF15140.8, score=86.5]} {RNA1509_13769, RNA1509_51431} {RNA1310_40941.1, RNA1509_13769, RNA1509_51431} {RNA1509_13769, RNA1509_51431, RNA815_34286.1} | |
77. | MligTC455_52926 | 9 | 0.18 | Mlig455_024897 | Neo: - Age: - |
0.972 | - | 0.972 | - | - | - | - | Mlig455_024897 {REF} {Length: 428} {NoTransDecoderORF} {RNA1310_119495} | |
78. | MligTC455_15884 | 26 | 0.54 | Mlig455_066451 | Neo: - Age: - Region-enriched R2: 9.632/0.00394 |
0.971 | - | 0.971 | - | - | - | - | Mlig455_066451 {REF} {Length: 1468} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=20.9]} {RNA1310_27849} {RNA815_37376} | |
79. | MligTC455_33850 | 80 | 1.67 | Mlig455_015720 | Neo: - Age: - Region-enriched R2: 4.134/0.00338 |
0.971 | - | 0.971 | - | - | - | - | Mlig455_015720 {REF} {Length: 829} {RNA1509_37932} {RNA1310_98453} | |
80. | MligTC455_45880 | 278 | 5.8 | Mlig455_051498 | Neo: - Age: - Region-enriched R2: 5.081/0.00218 |
CALM2 | 0.971 | - | - | - | 0.971 | - | - | Mlig455_051498 {REF} {Length: 2328} {Pfam: EF-hand domain pair [PF13499.8, score=48.0]; EF-hand domain [PF14658.8, score=32.2]; EF-hand domain [PF13405.8, score=23.0]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=84.0, Expect=1e-20]; ENSG00000160014, CALM3, calmodulin 3, [Score=84.0, Expect=1e-20]; ENSG00000198668, CALM1, calmodulin 1, [Score=84.0, Expect=1e-20]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=84.0, Expect=9e-21]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=84.0, Expect=9e-21]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=84.0, Expect=9e-21]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=82.8, Expect=2e-20]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=82.8, Expect=1e-20]} {Smed: dd_Smed_v6_414_0_1, dd_Smed_v6_414_0_1, [Score=82.8, Expect=9e-21]} {RNA1509_41430} {RNA1310_44424} {RNA815_28870} |
81. | MligTC455_23239 | 32 | 0.67 | Mlig455_030867 | Neo: - Age: - |
PRKCB | 0.97 | - | 0.970 | - | - | - | - | Mlig455_030867 {REF} {Length: 3999} {Pfam: Protein kinase domain [PF00069.27, score=228.1]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=131.0]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=118.5]; C2 domain [PF00168.32, score=93.9]; Protein kinase C terminal domain [PF00433.26, score=35.3]; C1 domain [PF03107.18, score=22.2]; Kinase-like [PF14531.8, score=19.0]} {Human: ENSG00000166501, PRKCB, protein kinase C beta, [RH, Score=962, Expect=0.0]; ENSG00000154229, PRKCA, protein kinase C alpha, [RH, Score=952, Expect=0.0]} {Mouse: ENSMUSG00000052889, Prkcb, protein kinase C, beta, [RH, Score=963, Expect=0.0]; ENSMUSG00000050965, Prkca, protein kinase C, alpha, [RH, Score=952, Expect=0.0]} {Dmel: FBgn0003091, Pkc53E, Protein C kinase 53E, [RH, Score=941, Expect=0.0]} {Celegans: WBGene00004033, pkc-2, Protein kinase C-like 2, [RH, Score=940, Expect=0.0]} {Smed: dd_Smed_v6_4244_0_2, dd_Smed_v6_4244_0_2, [RH, Score=1049, Expect=0.0]} {RNA1509_51260} {RNA1310_9698, RNA1509_51260} {RNA1509_51260, RNA815_24870} |
82. | MligTC455_31240 | 329 | 6.85 | Mlig455_010150 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.167 Region-enriched R4: 6.247/0.01251 |
0.97 | - | - | - | 0.970 | - | - | Mlig455_010150 {REF} {Length: 557} {RNA1509_16524, RNA1509_26056} {RNA1310_74791.1, RNA1509_16524} {RNA1509_16524, RNA815_37646} | |
83. | MligTC455_47735 | 70 | 1.45 | Mlig455_054644 | Neo: - Age: - Region-enriched R3: 5.950/0.00023 |
0.97 | - | - | - | 0.970 | - | - | Mlig455_054644 {REF} {Length: 804} {Pfam: Domain of unknown function (DUF4573) [PF15140.8, score=37.7]} {RNA1509_39145} {RNA1310_42379.1} {RNA815_34286.1} | |
84. | MligTC455_51261 | 88 | 1.84 | Mlig455_036952 | Neo: - Age: Down-Down-Down |
0.97 | - | - | - | 0.970 | - | - | Mlig455_036952 {REF} {Length: 3945} {TRANSSPLICED} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=92.5]; Domain of unknown function (DUF4615) [PF15393.8, score=57.4]} {Mouse: ENSMUSG00000063236, 1110038F14Rik, RIKEN cDNA 1110038F14 gene, [RH, Score=55.1, Expect=4e-08]} {Dmel: FBgn0038673, CG14286, [RH, Score=53.9, Expect=5e-08]} {Smed: dd_Smed_v6_10522_0_1, dd_Smed_v6_10522_0_1, [Score=63.2, Expect=3e-10]} {RNA1509_16748} {RNA1310_30400} {RNA815_28361} | |
85. | MligTC455_24270 | 71 | 1.47 | Mlig455_005120 | Neo: - Age: - |
CHRNA7 | 0.969 | - | 0.969 | - | - | - | - | Mlig455_005120 {REF} {Length: 1530} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=66.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=148, Expect=4e-39]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=147, Expect=5e-39]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=146, Expect=2e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=1e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=135, Expect=5e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=9e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=133, Expect=4e-34]} {RNA1509_43533} {RNA1310_20839.2} {RNA815_22406} |
86. | MligTC455_27186 | 28 | 0.57 | Mlig455_010236 | Neo: - Age: logFC(26M/2M)=-1.855 |
0.969 | - | - | - | 0.969 | - | - | Mlig455_010236 {REF} {Length: 486} {RNA1509_7146} {RNA1310_76234.2} {RNA815_34947.2} | |
87. | MligTC455_45881 | 285 | 5.94 | Mlig455_051535 | Neo: Irradiation Age: Up-Down-Down Region-enriched R2: 4.287/0.00883 |
CALM2 | 0.969 | - | - | - | 0.969 | - | - | Mlig455_051535 {REF} {Length: 1911} {Pfam: EF-hand domain pair [PF13499.8, score=44.7]; EF-hand domain [PF14658.8, score=28.5]; EF-hand domain [PF13405.8, score=18.6]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=83.2, Expect=5e-18]; ENSG00000198668, CALM1, calmodulin 1, [Score=83.2, Expect=1e-18]; ENSG00000160014, CALM3, calmodulin 3, [Score=82.8, Expect=2e-18]} {Mouse: ENSMUSG00000036438, Calm2, calmodulin 2, [Score=82.8, Expect=1e-18]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=82.8, Expect=1e-18]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=82.8, Expect=1e-18]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=82.4, Expect=2e-18]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=82.4, Expect=1e-18]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=82.4, Expect=1e-18]} {RNA1509_41430} {RNA1310_57772} {RNA815_28870} |
88. | MligTC455_50029 | 35 | 0.74 | Mlig455_010619, Mlig455_010708 | Neo: - Age: - |
FOXA1 | 0.969 | - | - | - | 0.969 | - | - | Mlig455_010619 {REF} {Length: 1170} {Pfam: Forkhead domain [PF00250.20, score=110.8]} {Human: ENSG00000129514, FOXA1, forkhead box A1, [Score=168, Expect=3e-48]; ENSG00000170608, FOXA3, forkhead box A3, [Score=164, Expect=1e-47]; ENSG00000125798, FOXA2, forkhead box A2, [Score=163, Expect=2e-46]} {Mouse: ENSMUSG00000035451, Foxa1, forkhead box A1, [Score=167, Expect=3e-48]; ENSMUSG00000040891, Foxa3, forkhead box A3, [Score=164, Expect=7e-48]; ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=164, Expect=7e-47]} {Dmel: FBgn0000659, fkh, fork head, [Score=169, Expect=2e-48]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=150, Expect=3e-42]} {Smed: dd_Smed_v6_10718_0_4, dd_Smed_v6_10718_0_4, [Score=175, Expect=2e-51]} Mlig455_010708 {REF} {Length: 1194} {Pfam: Forkhead domain [PF00250.20, score=110.9]} {Human: ENSG00000129514, FOXA1, forkhead box A1, [Score=168, Expect=3e-48]; ENSG00000125798, FOXA2, forkhead box A2, [Score=163, Expect=2e-46]; ENSG00000170608, FOXA3, forkhead box A3, [Score=163, Expect=1e-47]} {Mouse: ENSMUSG00000035451, Foxa1, forkhead box A1, [Score=167, Expect=4e-48]; ENSMUSG00000040891, Foxa3, forkhead box A3, [Score=165, Expect=2e-48]; ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=164, Expect=9e-47]} {Dmel: FBgn0000659, fkh, fork head, [Score=168, Expect=2e-48]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=151, Expect=2e-42]} {Smed: dd_Smed_v6_10718_0_3, dd_Smed_v6_10718_0_3, [Score=175, Expect=2e-51]} |
89. | MligTC455_08724 | 7 | 0.14 | Mlig455_008878 | Neo: - Age: - |
TENT5D | 0.968 | - | 0.968 | - | - | - | - | Mlig455_008878 {REF} {Length: 2482} {Pfam: Nucleotidyltransferase [PF07984.14, score=304.0]} {Human: ENSG00000174016, TENT5D, terminal nucleotidyltransferase 5D, [Score=248, Expect=8e-77]; ENSG00000183508, TENT5C, terminal nucleotidyltransferase 5C, [Score=246, Expect=4e-76]; ENSG00000112773, TENT5A, terminal nucleotidyltransferase 5A, [Score=239, Expect=1e-72]} {Mouse: ENSMUSG00000073007, Tent5d, terminal nucleotidyltransferase 5D, [Score=244, Expect=8e-76]; ENSMUSG00000044468, Tent5c, terminal nucleotidyltransferase 5C, [Score=243, Expect=3e-75]; ENSMUSG00000032265, Tent5a, terminal nucleotidyltransferase 5A, [Score=242, Expect=2e-74]} {Dmel: FBgn0050497, CG30497, [Score=244, Expect=2e-74]} {Celegans: WBGene00004131, pqn-44, Prion-like-(Q/N-rich)-domain-bearing protein, [RH, Score=209, Expect=2e-61]} {Smed: dd_Smed_v6_11571_0_1, dd_Smed_v6_11571_0_1, [Score=254, Expect=8e-80]} {RNA1310_116080} |
90. | MligTC455_11578 | 85 | 1.77 | Mlig455_045778 | Neo: - Age: - |
0.968 | - | - | 0.968 | - | - | - | Mlig455_045778 {REF} {Length: 1487} {TRANSSPLICED} {Pfam: 7 transmembrane receptor (Secretin family) [PF00002.26, score=39.4]} {RNA1509_6409} {RNA1310_984} {RNA815_7594.1} | |
91. | MligTC455_43686 | 326 | 6.79 | Mlig455_022166, Mlig455_055777 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.570 Region-enriched R3: 6.671/0.00000 |
0.968 | - | - | - | 0.968 | - | - | Mlig455_022166 {REF} {Length: 612} {RNA1310_23536} {RNA815_45816} Mlig455_055777 {REF} {Length: 584} {RNA1310_23536} {RNA815_45816} |
|
92. | MligTC455_46513 | 464 | 9.68 | Mlig455_035260 | Neo: - Age: - Region-enriched R3: 3.764/0.00361 |
0.968 | - | - | - | 0.968 | - | - | Mlig455_035260 {REF} {Length: 657} {RNA1509_5889} {RNA1310_52884} {RNA815_23505} | |
93. | MligTC455_18055 | 48 | 1 | Mlig455_037951 | Neo: - |
ANKRD50 | 0.967 | - | - | - | 0.967 | - | - | Mlig455_037951 {REF} {Length: 3486} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=143.0]; Ankyrin repeats (many copies) [PF13637.8, score=109.2]; Ankyrin repeat [PF13606.8, score=63.4]; Ankyrin repeats (many copies) [PF13857.8, score=51.7]; Ankyrin repeat [PF00023.32, score=47.4]} {Human: ENSG00000151458, ANKRD50, ankyrin repeat domain 50, [Score=114, Expect=3e-25]} {Mouse: ENSMUSG00000044864, Ankrd50, ankyrin repeat domain 50, [Score=114, Expect=2e-25]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=84.3, Expect=3e-16]} {Celegans: WBGene00012124, T28D6.4, [Score=71.6, Expect=1e-12]} {Smed: dd_Smed_v6_5303_0_2, dd_Smed_v6_5303_0_2, [Score=104, Expect=6e-23]} {RNA1509_58829} {RNA1310_31738} {RNA815_33130} |
94. | MligTC455_18140 | 171 | 3.56 | Mlig455_033232 | Neo: - Age: Up-Down-Down Region-specific R2: 6.925 Region-enriched R2: 6.274/0.02921 |
TRPC5 | 0.967 | - | 0.967 | - | - | - | - | Mlig455_033232 {REF} {Length: 4524} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.2]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.5]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=742, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=745, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=742, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=696, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1016, Expect=0.0]} {RNA1509_34138} {RNA1310_12839} {RNA815_17637} |
95. | MligTC455_27143 | 5346 | 111.38 | Mlig455_010167 | Neo: - Age: Down-Down-Down Region-enriched R3: 6.246/0.00000 |
0.967 | - | - | - | 0.967 | - | - | Mlig455_010167 {REF} {Length: 734} {Pfam: Domain of unknown function (DUF4576) [PF15144.8, score=26.9]; Glycine rich protein family [PF07172.13, score=19.2]; Protein of unknown function (DUF2615) [PF11027.10, score=18.9]} {RNA1509_3211} {RNA1310_56673} {RNA815_23606.2} | |
96. | MligTC455_12978 | 63 | 1.31 | Mlig455_023948 | Neo: - Age: - |
0.966 | - | 0.966 | - | - | - | - | Mlig455_023948 {REF} {Length: 2929} {RNA1310_80095.1} | |
97. | MligTC455_19225 | 26 | 0.54 | Mlig455_018507 | Neo: - Age: - |
SCNN1B | 0.966 | - | 0.966 | - | - | - | - | Mlig455_018507 {REF} {Length: 2590} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=142.8]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=59.3, Expect=1e-08]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=60.8, Expect=1e-09]} {Smed: dd_Smed_v6_17245_0_1, dd_Smed_v6_17245_0_1, [Score=49.3, Expect=5e-06]} {RNA1509_52685} {RNA1310_32081} {RNA815_49764} |
98. | MligTC455_23833 | 17 | 0.36 | Mlig455_016419 | Neo: - Age: - |
MYT1 | 0.966 | - | 0.966 | - | - | - | - | Mlig455_016419 {REF} {Length: 2682} {Pfam: Zinc finger, C2HC type [PF01530.20, score=79.8]} {Human: ENSG00000196132, MYT1, myelin transcription factor 1, [RH, Score=131, Expect=5e-32]; ENSG00000276876, MYT1, myelin transcription factor 1, [RH, Score=131, Expect=5e-32]; ENSG00000275018, AL121581.1, novel transcript, [RH, Score=130, Expect=1e-31]; ENSG00000147488, ST18, ST18, C2H2C-type zinc finger, [RH, Score=125, Expect=3e-30]} {Mouse: ENSMUSG00000010505, Myt1, myelin transcription factor 1, [RH, Score=132, Expect=6e-33]; ENSMUSG00000061911, Myt1l, myelin transcription factor 1-like, [RH, Score=129, Expect=1e-31]; ENSMUSG00000033740, St18, suppression of tumorigenicity 18, [RH, Score=126, Expect=2e-30]} {Dmel: FBgn0263772, CG43689, [RH, Score=99.0, Expect=1e-21]} {Celegans: WBGene00009939, ztf-11, Zinc finger putative Transcription Factor family, [RH, Score=121, Expect=1e-29]} {Smed: dd_Smed_v6_80183_0_2, dd_Smed_v6_80183_0_2, [Score=127, Expect=4e-34]} {RNA1310_143021} |
99. | MligTC455_33853 | 7 | 0.14 | Mlig455_029940 | Neo: - Age: - |
MGAT1 | 0.966 | - | 0.966 | - | - | - | - | Mlig455_029940 {REF} {Length: 2088} {Pfam: GNT-I family [PF03071.17, score=204.9]} {Human: ENSG00000131446, MGAT1, mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase, [Score=153, Expect=4e-41]} {Mouse: ENSMUSG00000020346, Mgat1, mannoside acetylglucosaminyltransferase 1, [Score=166, Expect=4e-46]} {Dmel: FBgn0034521, Mgat1, Mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase 1, [Score=172, Expect=3e-48]} {Celegans: WBGene00001639, gly-14, GLYcosylation related; UDP-N-acetylglucosamine:a-3-D-mannoside b-1,2-N-acetylglucosaminyltransferase I, [Score=144, Expect=2e-38]} {Smed: dd_Smed_v6_13024_0_1, dd_Smed_v6_13024_0_1, [Score=158, Expect=1e-43]} {RNA1310_114996} |
100. | MligTC455_51648 | 71 | 1.49 | Mlig455_055670 | Neo: - Age: Down-Down-Up |
0.965 | - | - | - | 0.965 | - | - | Mlig455_055670 {REF} {Length: 3196} {Pfam: Integrase core domain [PF00665.28, score=19.1]; Integrase core domain [PF13683.8, score=19.0]} {Smed: dd_Smed_v6_94688_0_1, dd_Smed_v6_94688_0_1, [Score=77.4, Expect=4e-18]} {RNA1509_24311} {RNA1310_35472} {RNA815_10275} |